Capricor Therapeutics (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapies for rare diseases. At the forefront of our innovation is Deramiocel ( CAP-1002 ),…
Cookies?
A session cookie keeps you signed in. If you accept, we also use analytics cookies (Google Analytics and PostHog) to understand usage. Learn more
We couldn't check your fit for this role — add a CV to your profile to see it next time.